CELLforCURE by SEQENS


CELLforCURE by SEQENS, based near Paris, is a leading CDMO in cell and gene therapy, specializing in both autologous and allogeneic Advanced Therapy Medicinal Products (ATMPs). With over a decade of expertise, we offer comprehensive end-to-end services — from Phase I clinical trials to full-scale commercial manufacturing. Our cutting-edge, 10,000 sqm “one-stop-shop” facility includes 2,200 sqm of GMP-certified production space, housing 48 cleanrooms dedicated to ATMP manufacturing


 Products

  • End-to-end ATMP CDMO FOR CLINICAL & COMMERCIAL CELL & GENE THERAPY MANUFACT
    Large scale capacities
    3,000 m2 GMP area
    48 cleanrooms grade B/C
     
    CAR-T Manufacturing Expertise
    +600 autologous commercial doses
    +10,000 allogeneic clinical vials...